227 related articles for article (PubMed ID: 11933191)
21. Signature-based analysis of MET proto-oncogene mutations using DHPLC.
Nickerson ML; Weirich G; Zbar B; Schmidt LS
Hum Mutat; 2000; 16(1):68-76. PubMed ID: 10874308
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
24. Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods.
Nickerson ML; Warren MB; Zbar B; Schmidt LS
Hum Mutat; 2001 Mar; 17(3):210-9. PubMed ID: 11241843
[TBL] [Abstract][Full Text] [Related]
25. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
26. Detection of CFTR mutations using temporal temperature gradient gel electrophoresis.
Wong LJ; Alper OM
Electrophoresis; 2004 Aug; 25(15):2593-601. PubMed ID: 15300780
[TBL] [Abstract][Full Text] [Related]
27. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
[TBL] [Abstract][Full Text] [Related]
28. The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes.
Marsh DJ; Howell VM
Methods Mol Biol; 2010; 653():133-45. PubMed ID: 20721741
[TBL] [Abstract][Full Text] [Related]
29. CFTR mutations in the Algerian population.
Loumi O; Ferec C; Mercier B; Creff J; Fercot B; Denine R; Grangaud JP
J Cyst Fibros; 2008 Jan; 7(1):54-9. PubMed ID: 17572159
[TBL] [Abstract][Full Text] [Related]
30. Segregation analysis in cystic fibrosis at-risk family demonstrates that the M348K CFTR mutation is a rare innocuous polymorphism.
D'Apice MR; Gambardella S; Russo S; Lucidi V; Nardone AM; Pietropolli A; Novelli G
Prenat Diagn; 2004 Dec; 24(12):981-3. PubMed ID: 15614862
[TBL] [Abstract][Full Text] [Related]
31. Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic Navigator software.
Colley J; Jones S; Dallosso AR; Maynard JH; Humphreys V; Dolwani S; Sampson JR; Cheadle JP
Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010685
[TBL] [Abstract][Full Text] [Related]
32. Screening methods for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in non-human primates.
Glavac D; Ravnik-Glavac M; Potocnik U; Dean M; Wine J
Pflugers Arch; 2000; 439(3 Suppl):R12-3. PubMed ID: 10653125
[TBL] [Abstract][Full Text] [Related]
33. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
Fackenthal DL; Chen PX; Das S
Methods Mol Biol; 2005; 311():73-96. PubMed ID: 16100401
[TBL] [Abstract][Full Text] [Related]
34. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
[TBL] [Abstract][Full Text] [Related]
35. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
[TBL] [Abstract][Full Text] [Related]
36. Denaturing HPLC-based approach for detection of COL7A1 gene mutations causing dystrophic epidermolysis bullosa.
Posteraro P; Pascucci M; Colombi M; Barlati S; Giannetti A; Paradisi M; Mustonen A; Zambruno G; Castiglia D
Biochem Biophys Res Commun; 2005 Dec; 338(3):1391-401. PubMed ID: 16271705
[TBL] [Abstract][Full Text] [Related]
37. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.
Frenţescu L; Brownsell E; Hinks J; Malone G; Shaw H; Budişan L; Bulman M; Schwarz M; Pop L; Filip M; Tomescu E; Moşescu S; Popa I; Benga G
J Cyst Fibros; 2008 Sep; 7(5):423-8. PubMed ID: 18467194
[TBL] [Abstract][Full Text] [Related]
38. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
[TBL] [Abstract][Full Text] [Related]
39. Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.
Yu B; Sawyer NA; Caramins M; Yuan ZG; Saunderson RB; Pamphlett R; Richmond DR; Jeremy RW; Trent RJ
J Clin Pathol; 2005 May; 58(5):479-85. PubMed ID: 15858117
[TBL] [Abstract][Full Text] [Related]
40. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis.
Bénit P; Bonnefont JP; Kara Mostefa A; Francannet C; Munnich A; Ray PF
Prenat Diagn; 2001 Apr; 21(4):279-83. PubMed ID: 11288117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
